David Boberski

From MarketsWiki
Jump to: navigation, search
FTSE Russell banner 2016.gif
David Boberski
Occupation Managing Director, OTC Research and New Product Development
Employer CME Group
LinkedIn Profile
Website www.cmegroup.com

David Boberski is managing director, OTC Research and New Product Development, at the CME Group. He was named to that position on February 26, 2009. He will be responsible for identifying and developing new product opportunities in credit and interest rates, adapting existing CME Group products and services to the over-the-counter (OTC) markets and educating CME Group customers on CME Group credit and interest rate products. He reports to Julie Winkler, Managing Director, Research and Product Development.[1]

Background

Before joining CME Group, Boberski worked as a consulting expert for the U.S. Commodity Futures Trading Commission's Division of Enforcement. He also has served as Executive Director and Head of Exchange Traded Derivatives Research for UBS Investment Bank and Managing Director, Principal and Head of Interest Rate Strategy for Bear, Stearns and Co.. He also worked as an Adjunct Professor in Portfolio Theory Economics at the University of Illinois.

He has published two books and has been named to the Institutional Investor All-American Research Team. He is a Series 3, 7, 16 and 63 Registered Representative.

Education

Boberski earned bachelor's degrees in economics and finance from the College of William and Mary, a master's degree in economics from the University of Chicago and a master's degree in finance from the University of Illinois.

References

  1. [{{{url}}} CME Group Names David Boberski as Managing Director, OTC Research and New Product Development]. CME Group.